• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱-紫外检测法同时测定人血清和药物制剂中的二甲双胍、西咪替丁、法莫替丁和雷尼替丁。

Simultaneous determination of metformin, cimetidine, famotidine, and ranitidine in human serum and dosage formulations using HPLC with UV detection.

作者信息

Arayne M Saeed, Sultana Najma, Zuberi M Hashim, Siddiqui Farhan Ahmed

机构信息

Department of Chemistry, University of Karachi, Karachi-75270, Pakistan.

出版信息

J Chromatogr Sci. 2010 Oct;48(9):721-5. doi: 10.1093/chromsci/48.9.721.

DOI:10.1093/chromsci/48.9.721
PMID:20875233
Abstract

A new, simple, and reliable reversed-phase high-performance liquid chromatographic method has been developed and validated for the simultaneous determination of metformin (Metf), cimetidine (Cimt), famotidine (Famt), and ranitidine (Rant) in their synthetic mixtures and tablet formulations. These drugs were separated on a Purospher Star RP18 endcapped (250 mm × 4.6 mm i.d.) column packed with 5-μm particles. The mobile phase, optimized through an experimental design, consisted of methanol-water-triethylamine (20:80:0.05), whose pH was adjusted to 3.0 with phosphoric acid (85%) pumped at a flow rate of 1.0 mL/min. UV detection was performed at 229 nm. The method was validated in the sample concentration range of 5-25 μg/mL for all the drugs, where it demonstrated good linearity with r = 0.9998, 0.9979, 0.9997, and 0.9987 (n = 6), respectively. For independent 100% level samples, the intra-day and inter-day precision was in the range i.e. < 2.0 for all the drugs. The method demonstrated robustness, resisting to small deliberate changes in pH, flow rate, and composition (organic:aqueous ratio) of the mobile phase. The limit of detection values were 0.071, 0.116, 0.134, and 0.110 μg/mL, while the limit of quantitation were 0.217, 0.352, 0.405, and 0.368 μg/mL for Metf, Cimt, Famt, and Rant, respectively. The applicability of the method was demonstrated by determining the drug content in pharmaceutical formulations, where it exhibited good performance.

摘要

已开发并验证了一种新的、简单且可靠的反相高效液相色谱法,用于同时测定合成混合物和片剂制剂中的二甲双胍(Metf)、西咪替丁(Cimt)、法莫替丁(Famt)和雷尼替丁(Rant)。这些药物在填充有5-μm颗粒的Purospher Star RP18封端(250 mm×4.6 mm内径)柱上分离。通过实验设计优化的流动相由甲醇-水-三乙胺(20:80:0.05)组成,用磷酸(85%)将其pH调节至3.0,以1.0 mL/min的流速泵送。在229 nm处进行紫外检测。该方法在所有药物的5-25μg/mL样品浓度范围内进行了验证,在此范围内分别显示出良好的线性,r = 0.9998、0.9979、0.9997和0.9987(n = 6)。对于独立的100%水平样品,所有药物的日内和日间精密度范围均<2.0。该方法表现出稳健性,能抵抗流动相pH、流速和组成(有机相:水相比例)的微小故意变化。二甲双胍、西咪替丁、法莫替丁和雷尼替丁的检测限分别为0.071、0.116、0.134和0.110μg/mL,定量限分别为0.217、0.352、0.405和0.368μg/mL。通过测定药物制剂中的药物含量证明了该方法的适用性,其表现良好。

相似文献

1
Simultaneous determination of metformin, cimetidine, famotidine, and ranitidine in human serum and dosage formulations using HPLC with UV detection.采用高效液相色谱-紫外检测法同时测定人血清和药物制剂中的二甲双胍、西咪替丁、法莫替丁和雷尼替丁。
J Chromatogr Sci. 2010 Oct;48(9):721-5. doi: 10.1093/chromsci/48.9.721.
2
Development of an HPLC method for the determination of ranitidine and cimetidine in human plasma following SPE.
J Pharm Biomed Anal. 2003 Sep 19;33(2):165-73. doi: 10.1016/s0731-7085(03)00265-6.
3
Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma.毛细管电泳中头柱场放大进样堆积法测定血浆中的西咪替丁、法莫替丁、尼扎替丁和雷尼替丁盐酸盐
Electrophoresis. 2001 Aug;22(13):2717-22. doi: 10.1002/1522-2683(200108)22:13<2717::AID-ELPS2717>3.0.CO;2-2.
4
Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.用于测定尿液中西咪替丁、雷尼替丁、法莫替丁和尼扎替丁的简单通用高效液相色谱 - 紫外法:应用于人体志愿者中雷尼替丁及其代谢物的分析
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 15;860(2):235-40. doi: 10.1016/j.jchromb.2007.10.029. Epub 2007 Nov 19.
5
A single LC-tandem mass spectrometry method for the simultaneous determination of four H2 antagonists in human plasma.一种用于同时测定人血浆中四种 H2 拮抗剂的单 LC-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):3953-9. doi: 10.1016/j.jchromb.2009.10.003. Epub 2009 Oct 8.
6
Development and validation of RP-HPLC method for simultaneous determination of cefpodoxime proxetil and H2 receptor antagonists in pharmaceutical dosage forms.反相高效液相色谱法同时测定药物制剂中头孢泊肟酯和H2受体拮抗剂的方法开发与验证
Pak J Pharm Sci. 2019 Mar;32(2 (Supplementary)):839-844.
7
Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products.同时对市售产品中的法莫替丁、盐酸雷尼替丁、西咪替丁和尼扎替丁进行高效液相色谱分析。
Drug Dev Ind Pharm. 1999 Mar;25(3):379-85. doi: 10.1081/ddc-100102186.
8
Simple and robust high-performance liquid chromatographic method for the determination of ranitidine in microvolumes of human serum.
J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):228-32. doi: 10.1016/s0378-4347(96)00515-4.
9
Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations.采用反相高效液相色谱法同时测定美洛昔康和甲磺酸普立地诺的方法开发与验证及其在药物制剂中的应用。
J Pharm Biomed Anal. 2008 Jan 22;46(2):219-25. doi: 10.1016/j.jpba.2007.09.011. Epub 2007 Sep 15.
10
Reliable method for the determination of ranitidine by liquid chromatography using a microvolume of plasma.
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Sep 25;795(1):141-4. doi: 10.1016/s1570-0232(03)00474-4.

引用本文的文献

1
Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment.透明质酸偶联二甲双胍-磷脂超声复合物:一种双相复合物构建方法用于纠正缺氧肿瘤微环境。
Int J Nanomedicine. 2021 Feb 11;16:1005-1019. doi: 10.2147/IJN.S297634. eCollection 2021.
2
Synthesis of Flower-like Nickel Hydroxide Nanosheets and Application in Electrochemical Determination of Famotidine.花状氢氧化镍纳米片的合成及其在法莫替丁电化学测定中的应用。
Iran J Pharm Res. 2020 Winter;19(1):120-137. doi: 10.22037/ijpr.2019.14257.12245.